Holen Sie sich die Stockscreener-App
38.27
3.38%
1.25
Handel nachbörslich:
38.30
0.03
+0.08%
Schlusskurs vom Vortag:
$37.02
Offen:
$37.59
24-Stunden-Volumen:
483.74K
Relative Volume:
0.60
Marktkapitalisierung:
$2.39B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-230.66M
KGV:
-9.1682
EPS:
-4.1742
Netto-Cashflow:
$-148.12M
1W Leistung:
-1.77%
1M Leistung:
+23.25%
6M Leistung:
+41.37%
1J Leistung:
+931.54%
1-Tages-Spanne:
$35.77
$38.74
1-Wochen-Bereich:
$35.77
$40.17
52-Wochen-Spanne:
$3.73
$47.84
Kodiak Sciences Inc Stock (KOD) Company Profile
Firmenname
Kodiak Sciences Inc
Sektor
Branche
Telefon
650-281-0850
Adresse
1250 PAGE MILL RD, PALO ALTO, CA
Compare KOD vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
38.27 | 2.32B | 0 | -230.66M | -148.12M | -4.1742 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.93 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.50 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-11 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-09-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-09-22 | Eingeleitet | Jefferies | Buy |
| 2025-08-14 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-12-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-05 | Eingeleitet | H.C. Wainwright | Neutral |
| 2023-12-11 | Fortgesetzt | Goldman | Sell |
| 2023-11-17 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-25 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-07-24 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-15 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-02 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-02-24 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2021-03-12 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-01 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-02-17 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-01-25 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-11-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-11-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-31 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-03 | Eingeleitet | Goldman | Buy |
| 2020-02-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-02-06 | Eingeleitet | SunTrust | Buy |
| 2020-01-08 | Eingeleitet | ROTH Capital | Buy |
| 2020-01-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-24 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-10-29 | Eingeleitet | Barclays | Overweight |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Buy |
| 2018-10-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Kodiak Sciences Inc Aktie (KOD) Neueste Nachrichten
Is Kodiak Sciences’ (KOD) Shift Into Russell Growth Indices Reframing Its Core Investment Story? - Sahm
Form 4 Kodiak Sciences Inc For: 2 July By Investing.com - Investing.com Nigeria
Kodiak Sciences (KOD) director receives grant of 17,731 stock options - Stock Titan
Director at Kodiak Sciences (KOD) receives 17,731 stock options award - Stock Titan
[Form 4] Kodiak Sciences Inc. Insider Trading Activity - Stock Titan
17,731 options granted to Kodiak (NASDAQ: KOD) board director - Stock Titan
Kodiak Sciences (KOD) director awarded stock options for 17,731 shares at $38.96 - Stock Titan
17,731 Kodiak Sciences (KOD) options granted tied to Baker funds - Stock Titan
Why Did KOD Stock Surge To A Four-Year High Today? - Stocktwits
KOD News | KODIAK SCIENCES INC (NASDAQ:KOD) - ChartMill
Kodiak Sciences Inc Q1 2026 Earnings: EPS Beat Despite Zero Revenue, Stock Gains 3.23%Earnings Call Transcript - dars.gov.et
Kodiak Sciences Inc.(NasdaqGM:KOD) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
LifeSci Capital Maintains Kodiak Sciences(KOD.US) With Buy Rating, Maintains Target Price $65 - Moomoo
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell 2000 Value Benchmark - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM:KOD) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) added to Russell 2000 Growth Benchmark - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) added to Russell 3000E Growth Benchmark - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell 3000E Index - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell Microcap Index - marketscreener.com
Enterprise value to EBIT forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Enterprise value to EBITDA forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Price to book forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Price to sales forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Enterprise value to revenue forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Price to earnings forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Kodiak Sciences, Inc. Actuals & Estimates (NASDAQ:KOD) - TradingView
KOD Forecast — Price Target — Prediction for 2027 - TradingView
KODKodiak Sciences Inc Options - Finviz
KODIAK SCIENCES INC (KOD) Stock Chart - ChartMill
Kodiak Sciences Inc (KOD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kodiak Sciences Inc (KOD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kodiak Sciences Inc (KOD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kodiak Sciences Inc (KOD) Institutional Confidence - TradingKey
Kodiak Sciences Inc (KOD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Kodiak Sciences Inc (KOD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kodiak Sciences Inc (KOD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kodiak Sciences Inc (KOD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kodiak Sciences Inc (KOD) Valuation: PE, PB & Fair Value Analysis - TradingKey
KOD Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Progress Temps Market SkepticismEarnings Decline Risk - newsline.com
Kodiak Sciences Inc Stock (US50012K1051): Quiet-day stock in focus after no fresh trigger was verifi - Ad-hoc-news.de
Kodiak Sciences: Clinical Redemption Is Turning Into Platform Leverage (NASDAQ:KOD) - Seeking Alpha
Kodiak Sciences (KOD) Edges Higher: Biotech Momentum Builds at $34.55ATR Stop - newsline.com
Kodiak stock rises 35% in 3 months: Here's what you need to know - MSN
Kodiak Sciences Inc. - MLQ.ai
Why Kodiak Sciences (KOD) Is Down 15.4% After Zenkuda’s Phase III GLOW2 Win And Accelerated Filing - Sahm
Kodiak Sciences Zenkuda Trial Win Puts Cash Needs And Growth In Focus - Sahm
Kodiak Sciences (KOD) Is Down 15.4% After Strong Zenkuda GLOW2 Data And Accelerated Filing Plans - Yahoo Finance
Kodiak Sciences CFO John Borgeson sold $1.02 million in NASDAQ:KOD shares By Investing.com - Investing.com South Africa
Kodiak Sciences CFO John Borgeson sold $1.02 million in NASDAQ:KOD shares - Investing.com Nigeria
Kodiak (KOD) CFO sells 30,000 shares under 10b5-1 trading plan - Stock Titan
Kodiak Sciences Inc. (KOD) Presents at Jefferies Global Healthcare Conference 2026Slideshow - Seeking Alpha
Finanzdaten der Kodiak Sciences Inc-Aktie (KOD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kodiak Sciences Inc-Aktie (KOD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BORGESON JOHN A. | Chief Financial Officer |
Jun 04 '26 |
Sale |
34.10 |
30,000 |
1,023,009 |
211,930 |
1.18%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):